PMCF shall be understood to be a continuous process that updates the clinical evaluation referred to in Article 61 and Part A of this Annex and shall be addressed in the manufacturer's post-market surveillance plan.
Is é a thuigfear le MLCI próiseas leantach chun an mheastóireacht chliniciúil dá dtagraítear in Airteagal 61 agus i gCuid A den Iarscríbhinn seo a nuashonrú agus tabharfar aghaidh air i bplean faireachais iarmhargaidh an mhonaróra.